Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 16 Oct 2017 |
2 | Journal Copy | 26 Feb 2018 |
3 | Letter | 06 Apr 2018 |
4 | Certificate | 07 Apr 2018 |
The application for Etaxib was made on 16 October 2017.
The trademark applicant for Etaxib is MACKENZIE PHARMACEUTICALS.
Etaxib is applied in class(es) 5.
Application for Etaxib is on Registered stage.
Application Id allotted to Etaxib is 3658545.
Trademark agent or attorney for the application is S.S. Datta & Associates.
Etaxib filed with the Intellectual property office as a WORD.